These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3154322)

  • 1. Pharmacokinetic drug interactions between digoxin and antiarrhythmic agents and calcium channel blocking agents: an appraisal of study methodology.
    Antman EM; Arnold JM; Friedman PL; Smith TW
    Cardiovasc Drugs Ther; 1987 Aug; 1(2):183-9. PubMed ID: 3154322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed-effect modeling for detection and evaluation of drug interactions: digoxin-quinidine and digoxin-verapamil combinations.
    Bauer LA; Horn JR; Pettit H
    Ther Drug Monit; 1996 Feb; 18(1):46-52. PubMed ID: 8848820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium antagonists--adverse drug interactions.
    Reicher-Reiss H; Neufeld HN; Ebner FX
    Cardiovasc Drugs Ther; 1987 Dec; 1(4):403-9. PubMed ID: 2908714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of cardiac glycoside drug interactions.
    Hooymans PM; Merkus FW
    Clin Pharm; 1985; 4(4):404-13. PubMed ID: 2412751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin in the 1980s.
    Minson RB; McRitchie RJ
    Med J Aust; 1987 Oct; 147(8):403-7, 410. PubMed ID: 3309595
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of dofetilide on the pharmacokinetics of digoxin.
    Kleinermans D; Nichols DJ; Dalrymple I
    Am J Cardiol; 2001 Jan; 87(2):248-50, A9-10. PubMed ID: 11152855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic interaction trial after repeated oral doses of imidapril and digoxin in healthy volunteers.
    Harder S; Thürmann PA
    Br J Clin Pharmacol; 1997 May; 43(5):475-80. PubMed ID: 9159562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of clinically relevant interactions between rivaroxaban--an oral, direct Factor Xa inhibitor--and digoxin or atorvastatin in healthy subjects.
    Kubitza D; Becka M; Roth A; Mueck W
    J Int Med Res; 2012; 40(5):1688-707. PubMed ID: 23206451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of permeability-limited physiologically-based pharmacokinetic models: part II - prediction of P-glycoprotein mediated drug-drug interactions with digoxin.
    Neuhoff S; Yeo KR; Barter Z; Jamei M; Turner DB; Rostami-Hodjegan A
    J Pharm Sci; 2013 Sep; 102(9):3161-73. PubMed ID: 23686764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between digoxin and calcium antagonists and antiarrhythmic drugs.
    Belz GG; Doering W; Munkes R; Matthews J
    Clin Pharmacol Ther; 1983 Apr; 33(4):410-7. PubMed ID: 6831819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein.
    Wakasugi H; Yano I; Ito T; Hashida T; Futami T; Nohara R; Sasayama S; Inui K
    Clin Pharmacol Ther; 1998 Jul; 64(1):123-8. PubMed ID: 9695727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial.
    Hornestam B; Jerling M; Karlsson MO; Held P;
    Eur J Clin Pharmacol; 2003 Mar; 58(11):747-55. PubMed ID: 12634981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The interaction of antiarrhythmic drugs with other drugs].
    Yamaguchi I
    Kokyu To Junkan; 1985 Aug; 33(8):956-69. PubMed ID: 2866571
    [No Abstract]   [Full Text] [Related]  

  • 14. Itraconazole decreases renal clearance of digoxin.
    Jalava KM; Partanen J; Neuvonen PJ
    Ther Drug Monit; 1997 Dec; 19(6):609-13. PubMed ID: 9421099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model for the prediction of digoxin-drug interactions at the renal tubular cell level.
    Woodland C; Ito S; Koren G
    Ther Drug Monit; 1998 Apr; 20(2):134-8. PubMed ID: 9558126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No pharmacokinetic or pharmacodynamic interaction between digoxin and the oral direct thrombin inhibitor ximelagatran in healthy volunteers.
    Sarich TC; Schützer KM; Wollbratt M; Wall U; Kessler E; Eriksson UG
    J Clin Pharmacol; 2004 Aug; 44(8):935-41. PubMed ID: 15286098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
    Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
    Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of terbinafine on the pharmacokinetics of digoxin in healthy volunteers.
    Tarral A; Francheteau P; Guerret M
    Pharmacotherapy; 1997; 17(4):791-5. PubMed ID: 9250559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interaction studies and encainide use in renal and hepatic impairment.
    Quart BD; Gallo DG; Sami MH; Wood AJ
    Am J Cardiol; 1986 Aug; 58(5):104C-113C. PubMed ID: 2875643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.
    Rengelshausen J; Göggelmann C; Burhenne J; Riedel KD; Ludwig J; Weiss J; Mikus G; Walter-Sack I; Haefeli WE
    Br J Clin Pharmacol; 2003 Jul; 56(1):32-8. PubMed ID: 12848773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.